MA-BRIGHTCOVE-INC
14.7.2020 15:02:53 CEST | Business Wire | Press release
Brightcove Inc. (NASDAQ: BCOV), the world’s leading video technology platform, today announced the expansion of the Brightcove Global Partner Program , designed to further extend the power of video to reach global audiences quickly and easily. With a broad portfolio of partners specifically focused on media and enterprise organizations, the Brightcove Global Partner Program broadens the reach of Brightcove’s leading video technology solutions, which help fuel innovation and drive transformative business strategies with video.
Video is now a requirement to be a successful business. Brightcove’s Global Partner Program makes video technology readily available to organizations globally and enables them to implement it quickly through the channels that align best with their business models. By building a community of world-class partners, Brightcove is further democratizing the consumption of video, enabling companies around the world to bring their stories to viewers everywhere.
The newly-expanded program accommodates forward-thinking companies committed to ensuring the best experience for customers and end-users. The program consists of three types of partners:
- Referral Partners: Partners that refer their clients to Brightcove directly for a full video solution.
- Solution Partners: Systems integrators and resellers that build full video management solutions for their enterprise and media clients.
- Master License Partners: Partners that deliver Brightcove’s video technology and solutions as a managed service provider to clients of all sizes that demand the quality, choice, and support that Brightcove provides.
The Master License Partner program puts the full Brightcove platform within reach for all size clients. This new program allows Master License Partners to build upon their expertise, keeping them front and center to their clients, and now they are able to deliver world-class Brightcove video to their customers. Regardless of size, content type, and location, partners and clients alike are able to leverage leading video technology backed by Brightcove.
“As we continue to help enterprises broadcast their video content online, we want to ensure we’re offering them the most robust and premier video solutions available on the market,” said Blaise Kremer, Co-Founder, NovaStream. “Brightcove’s solutions allow the organizations we work with to enhance the delivery of their video content to their audiences, resulting in broader reach and exceptional viewing experiences. We are excited to be a part of Brightcove’s Partner Program, and look forward to helping more companies reap the benefits of video.”
"We are thrilled to be a part of Brightcove’s Global Partner Network and to help our customers stay at the forefront of the video revolution,” said Nuthapong Temsiripong, CEO, Digital Solution International Co., Ltd. “We have a long-standing relationship with Brightcove and have worked closely together to help media companies reduce their video streaming costs and increase revenue. As we move into the new partner program with additional enhancements and resources, we are excited to see our mutual customers continue to succeed with video.”
“Brightcove is committed to providing a strong global partner and channel ecosystem to support the demanding video needs for our customers,” said Lynn D. Tinney, Vice President, Global Partners at Brightcove. “Customers are our number one priority and we have enhanced our global partner program to enable them to deliver exceptional video experiences and exceed their audience’s expectations. Our partners offer services and solutions that are at the forefront of the digital transformation and with Brightcove as the core technology powering this network, we enable organizations that are serious about video to deliver secure and reliable content to viewers around the world.”
For more information on the Brightcove Global Partner Program, visit: https://www.brightcove.com/en/become-a-partner
About Brightcove Inc. (NASDAQ: BCOV)
We are the people behind the world’s leading video technology platform. With our award-winning technology and services, we help organizations in more than 70 countries meet business challenges and create strategic opportunities by inspiring, entertaining, and engaging their audiences through video.
Since Brightcove was established in 2004, we have consistently pushed boundaries to create a platform for people who are serious about video: one that is robust, scalable, and intuitive. Benefiting from a global infrastructure, unrivalled customer support, an extensive partner ecosystem, and relentless investment in R&D, Brightcove video sets the standard for professional grade video management, distribution, and monetization. To learn more, visit www.brightcove.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200714005607/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom